Epidemiology of Multidrug-resistant Organisms in Africa
Journal Title: Mediterranean Journal of Infection, Microbes and Antimicrobials - Year 2019, Vol 8, Issue 1
Abstract
Multidrug-resistant organisms/bacteria (MDROs) have significant health implications that either have not been addressed or received only limited attention, especially in resource-constrained settings such as Africa, where access to newer, often costly antibiotics is limited. Acquisition of MDROs has been linked with poorer clinical outcomes and prolonged hospitalization. The evolution and spread of MDROs is influenced by factors such as selective pressure exerted by indiscriminate use of antimicrobials in both agriculture and medicine, lack of prescribing skills and training, lack of access to rapid and reliable diagnostics, suboptimal surveillance, as well as poor implementation and adherence to prevention measures. Reports indicate increased occurrence of MDROs in Africa, including members of Enterobacteriaceae which are often implicated in bloodstream, urinary tract, abdomen, skin and soft tissue infections. However, serious data limitation and underreporting are major hurdles that continue to hinder our understanding of the impact of antimicrobial resistance. In this review, we sought to address this gap by providing up-to-date data on the epidemiology of MDROs across the continent, including data on their prevalence and current detection and prevention methods.
Authors and Affiliations
Bashar Haruna GULUMBE, Abdullahi Adamu FAGGO
Keywords
Related Articles
- EP ID EP689286
- DOI 10.4274/mjima.galenos.2019.2019.25
- Views 131
- Downloads 0
Chronic Hepatitis C Treatment with New Antiviral Agents
Recent advances in our knowledge of hepatitis C virus (HCV) molecular biology have enabled improvements in the efficacy and tolerability of HCV treatment, and in this regard many direct-acting antiviral (DAA) agents have...
Recommendations for Intra-abdominal Infections “Consensus Report”
Guidelines include recommendations of experts from various specialties within a topic in consideration of data specific to each country. However, to date there has not been a guideline standardizing the nomenclature and...
Frequency of Hepatitis B Virus Screening in Patients with Systemic Lupus Erythematosus
Introduction: Immunosuppressive drug use is common in the treatment of systemic lupus erythematosus (SLE). In cases receiving immunosuppressive therapy, screening for hepatitis B reactivation risk is also recommended. In...
An Unusual Case of Orf with Erythema Multiforme and Vesiculo-bullous Lesions after Eid al-Adha
No Abstract
Clinical and Laboratory Features of Travel-associated Malaria: A University Hospital Experience
Introduction: Malaria remains an ongoing challenge despite the fact that it seems to have been eradicated in Turkey since 2011. This study aimed to evaluate the status of antimalarial prophylaxis, clinical and laboratory...